All Insights White Paper Challenges To Traditional Pharma Incentive Plan Design For Today’s Rapidly Changing Pharmaceutical Environment

    Challenges To Traditional Pharma Incentive Plan Design For Today’s Rapidly Changing Pharmaceutical Environment

    Incentive Compensation

    Challenges To Traditional Pharma Incentive Plan Design For Today’s Rapidly Changing Pharmaceutical Environment

    Adapting incentive compensation plans for a transforming pharma environment.

    Download White Paper
    Challenges To Traditional Pharma Incentive Plan Design For Today’s Rapidly Changing Pharmaceutical Environment

    Changes in emerging environmental trends facing the pharma industry are requiring companies to rethink different strategic and operational sales force plans that ultimately drive new outcome measures. Among these sales force changes are considerations to implement incentive compensation designs that move away from traditional Rx-volume measurement. Despite noted challenges, this paper explores why companies need to consider developing the right incentive compensation plan design to drive appropriate behaviors and activities that affect new outcomes in response to environmental trends in an ever-changing pharma world.

    Contact us at insights@axtria.com with any questions.

    Click here to learn more about our Incentive Compensation Capabilities.

    Learn More linkClick Here To Learn More About Axtria Incentive Compensation Benchmarking Study – 2020 Results

    Complete the brief form to download the white paper

    Recommended insights

    Adapting Pharma Incentive Plans to the Changing Landscape

    Case Study

    Revolutionizing Information Access and Decision-Making With Generative AI for a Top 5 Pharma

    Adapting Pharma Incentive Plans to the Changing Landscape

    White Paper

    Dynamic Activity Planning: Empowering the Field Force to Elevate Customer Engagement

    Adapting Pharma Incentive Plans to the Changing Landscape

    White Paper

    Managing Sales Operations in a Changing Environment: GLP-1 Drugs and Their Surprise Impact on the MedTech Market